Selected research
Industry Research
Thromboelastography Machine Industry Research Report 2026
Market perspective
The global Thromboelastography Machine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Thromboelastography Machine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Thromboelastography Machine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Thromboelastography Machine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Thromboelastography Machine include Framar Hemologix Srl, Haemonetics, Sienco, WerfenLife, Bio-zircon, Guizhou Jinjiu Biotech, Lepu Technology, Medcaptain and Ud-bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Thromboelastography Machine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Thromboelastography Machine Market by Company
Framar Hemologix Srl
Haemonetics
Sienco
WerfenLife
Bio-zircon
Guizhou Jinjiu Biotech
Lepu Technology
Medcaptain
Ud-bio
Render
Improve Medical
Zhejiang Shengyu
Chongqing Dingrun
Thromboelastography Machine Segment by Type
Single and Double Channels
Four and Six Channels
Others
Thromboelastography Machine Segment by Application
Hospital and Clinics
Laboratory
Maternal and Child Health Service
Others
Thromboelastography Machine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Thromboelastography Machine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Thromboelastography Machine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Thromboelastography Machine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Thromboelastography Machine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Thromboelastography Machine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Thromboelastography Machine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single and Double Channels
- Four and Six Channels
- Others
Applications
- Hospital and Clinics
- Laboratory
- Maternal and Child Health Service
- Others
Companies covered
- Framar Hemologix Srl
- Haemonetics
- Sienco
- WerfenLife
- Bio-zircon
- Guizhou Jinjiu Biotech
- Lepu Technology
- Medcaptain
- Ud-bio
- Render
- Improve Medical
- Zhejiang Shengyu
- Chongqing Dingrun
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Thromboelastography Machine Market Size (2021-2032)
- 2.2.2 Global Thromboelastography Machine Sales (2021-2032)
- 2.2.3 Global Thromboelastography Machine Market Average Price (2021-2032)
- 2.3 Thromboelastography Machine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Single and Double Channels
- 2.3.3 Four and Six Channels
- 2.3.4 Others
- 2.4 Thromboelastography Machine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital and Clinics
- 2.4.3 Laboratory
- 2.4.4 Maternal and Child Health Service
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Thromboelastography Machine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Thromboelastography Machine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Thromboelastography Machine Revenue of Manufacturers (2021-2026)
- 3.4 Global Thromboelastography Machine Average Price by Manufacturers (2021-2026)
- 3.5 Global Thromboelastography Machine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Thromboelastography Machine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Thromboelastography Machine, Product Type & Application
- 3.8 Global Manufacturers of Thromboelastography Machine, Established Date
- 3.9 Global Thromboelastography Machine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Framar Hemologix Srl
- 4.1.1 Framar Hemologix Srl Company Information
- 4.1.2 Framar Hemologix Srl Business Overview
- 4.1.3 Framar Hemologix Srl Thromboelastography Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Framar Hemologix Srl Thromboelastography Machine Product Portfolio
- 4.1.5 Framar Hemologix Srl Recent Developments
- 4.2 Haemonetics
- 4.2.1 Haemonetics Company Information
- 4.2.2 Haemonetics Business Overview
- 4.2.3 Haemonetics Thromboelastography Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Haemonetics Thromboelastography Machine Product Portfolio
- 4.2.5 Haemonetics Recent Developments
- 4.3 Sienco
- 4.3.1 Sienco Company Information
- 4.3.2 Sienco Business Overview
- 4.3.3 Sienco Thromboelastography Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sienco Thromboelastography Machine Product Portfolio
- 4.3.5 Sienco Recent Developments
- 4.4 WerfenLife
- 4.4.1 WerfenLife Company Information
- 4.4.2 WerfenLife Business Overview
- 4.4.3 WerfenLife Thromboelastography Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 WerfenLife Thromboelastography Machine Product Portfolio
- 4.4.5 WerfenLife Recent Developments
- 4.5 Bio-zircon
- 4.5.1 Bio-zircon Company Information
- 4.5.2 Bio-zircon Business Overview
- 4.5.3 Bio-zircon Thromboelastography Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bio-zircon Thromboelastography Machine Product Portfolio
- 4.5.5 Bio-zircon Recent Developments
- 4.6 Guizhou Jinjiu Biotech
- 4.6.1 Guizhou Jinjiu Biotech Company Information
- 4.6.2 Guizhou Jinjiu Biotech Business Overview
- 4.6.3 Guizhou Jinjiu Biotech Thromboelastography Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Guizhou Jinjiu Biotech Thromboelastography Machine Product Portfolio
- 4.6.5 Guizhou Jinjiu Biotech Recent Developments
- 4.7 Lepu Technology
- 4.7.1 Lepu Technology Company Information
- 4.7.2 Lepu Technology Business Overview
- 4.7.3 Lepu Technology Thromboelastography Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Lepu Technology Thromboelastography Machine Product Portfolio
- 4.7.5 Lepu Technology Recent Developments
- 4.8 Medcaptain
- 4.8.1 Medcaptain Company Information
- 4.8.2 Medcaptain Business Overview
- 4.8.3 Medcaptain Thromboelastography Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Medcaptain Thromboelastography Machine Product Portfolio
- 4.8.5 Medcaptain Recent Developments
- 4.9 Ud-bio
- 4.9.1 Ud-bio Company Information
- 4.9.2 Ud-bio Business Overview
- 4.9.3 Ud-bio Thromboelastography Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Ud-bio Thromboelastography Machine Product Portfolio
- 4.9.5 Ud-bio Recent Developments
- 4.10 Render
- 4.10.1 Render Company Information
- 4.10.2 Render Business Overview
- 4.10.3 Render Thromboelastography Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Render Thromboelastography Machine Product Portfolio
- 4.10.5 Render Recent Developments
- 4.11 Improve Medical
- 4.11.1 Improve Medical Company Information
- 4.11.2 Improve Medical Business Overview
- 4.11.3 Improve Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Improve Medical Thromboelastography Machine Product Portfolio
- 4.11.5 Improve Medical Recent Developments
- 4.12 Zhejiang Shengyu
- 4.12.1 Zhejiang Shengyu Company Information
- 4.12.2 Zhejiang Shengyu Business Overview
- 4.12.3 Zhejiang Shengyu Thromboelastography Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Zhejiang Shengyu Thromboelastography Machine Product Portfolio
- 4.12.5 Zhejiang Shengyu Recent Developments
- 4.13 Chongqing Dingrun
- 4.13.1 Chongqing Dingrun Company Information
- 4.13.2 Chongqing Dingrun Business Overview
- 4.13.3 Chongqing Dingrun Thromboelastography Machine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Chongqing Dingrun Thromboelastography Machine Product Portfolio
- 4.13.5 Chongqing Dingrun Recent Developments
5 Global Thromboelastography Machine Market Scenario by Region
- 5.1 Global Thromboelastography Machine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Thromboelastography Machine Sales by Region: 2021-2032
- 5.2.1 Global Thromboelastography Machine Sales by Region: 2021-2026
- 5.2.2 Global Thromboelastography Machine Sales by Region: 2027-2032
- 5.3 Global Thromboelastography Machine Revenue by Region: 2021-2032
- 5.3.1 Global Thromboelastography Machine Revenue by Region: 2021-2026
- 5.3.2 Global Thromboelastography Machine Revenue by Region: 2027-2032
- 5.4 North America Thromboelastography Machine Market Facts & Figures by Country
- 5.4.1 North America Thromboelastography Machine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Thromboelastography Machine Sales by Country (2021-2032)
- 5.4.3 North America Thromboelastography Machine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Thromboelastography Machine Market Facts & Figures by Country
- 5.5.1 Europe Thromboelastography Machine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Thromboelastography Machine Sales by Country (2021-2032)
- 5.5.3 Europe Thromboelastography Machine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Thromboelastography Machine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Thromboelastography Machine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Thromboelastography Machine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Thromboelastography Machine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Thromboelastography Machine Market Facts & Figures by Country
- 5.7.1 South America Thromboelastography Machine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Thromboelastography Machine Sales by Country (2021-2032)
- 5.7.3 South America Thromboelastography Machine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Thromboelastography Machine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Thromboelastography Machine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Thromboelastography Machine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Thromboelastography Machine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Thromboelastography Machine Sales by Type (2021-2032)
- 6.1.1 Global Thromboelastography Machine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Thromboelastography Machine Sales Market Share by Type (2021-2032)
- 6.2 Global Thromboelastography Machine Revenue by Type (2021-2032)
- 6.2.1 Global Thromboelastography Machine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Thromboelastography Machine Revenue Market Share by Type (2021-2032)
- 6.3 Global Thromboelastography Machine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Thromboelastography Machine Sales by Application (2021-2032)
- 7.1.1 Global Thromboelastography Machine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Thromboelastography Machine Sales Market Share by Application (2021-2032)
- 7.2 Global Thromboelastography Machine Revenue by Application (2021-2032)
- 7.2.1 Global Thromboelastography Machine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Thromboelastography Machine Revenue Market Share by Application (2021-2032)
- 7.3 Global Thromboelastography Machine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Thromboelastography Machine Value Chain Analysis
- 8.1.1 Thromboelastography Machine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Thromboelastography Machine Production Mode & Process
- 8.2 Thromboelastography Machine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Thromboelastography Machine Distributors
- 8.2.3 Thromboelastography Machine Customers
9 Global Thromboelastography Machine Analyzing Market Dynamics
- 9.1 Thromboelastography Machine Industry Trends
- 9.2 Thromboelastography Machine Industry Drivers
- 9.3 Thromboelastography Machine Industry Opportunities and Challenges
- 9.4 Thromboelastography Machine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst